Fast Five Quiz: Iron Deficiency Anemia Management

James L. Harper, MD


August 06, 2021

Parenteral iron has been used safely and effectively in patients with inflammatory bowel disease with harmless adverse reactions.

Guidelines from the American College of Physicians indicate that a restrictive red blood cell transfusion strategy is recommended for hospitalized patients with coronary heart disease with the trigger hemoglobin threshold lowered to 7-8 g/dL. This guidance also stipulates that erythropoiesis-stimulating agents are not recommended for patients with mild to moderate anemia and either congestive heart failure or coronary heart disease.

Although restriction of activity is usually not required for iron deficiency anemia, it is recommended in patients with moderately severe iron deficiency anemia and significant cardiopulmonary disease until the anemia is adequately addressed with iron therapy.

Learn more about iron deficiency anemia treatment and management.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.